The Valley Desk

NCT05286762 · Interventional trial

Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301

Overall registry status Completed

Phase 3

Conditions ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder Combined, Attention-deficit Hyperactivity

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov